-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Sell on Novavax, Raises Price Target to $8

Benzinga·10/15/2026 17:06:10
Diffusion vocale
Citigroup analyst Geoff Meacham maintains Novavax (NASDAQ:NVAX) with a Sell and raises the price target from $7 to $8.